Proteome Sciences (PRM) Stock Price Down 14.3%
Proteome Sciences plc (LON:PRM)’s share price dropped 14.3% on Thursday . The company traded as low as GBX 2.40 ($0.03) and last traded at GBX 2.40 ($0.03). Approximately 782,034 shares changed hands during trading, an increase of 782% from the average daily volume of 88,695 shares. The stock had previously closed at GBX 2.80 ($0.04).
Separately, FinnCap reiterated a “corporate” rating on shares of Proteome Sciences in a report on Tuesday, November 6th.
In other news, insider Martin Diggle bought 500,000 shares of the stock in a transaction that occurred on Friday, November 16th. The stock was bought at an average cost of GBX 3 ($0.04) per share, for a total transaction of £15,000 ($19,600.16).
About Proteome Sciences (LON:PRM)
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. It delivers content for personalized medicine in the areas of biomarker services, biomarker assays, isobaric and isotopic reagents, and proprietary biomarkers. The company designs, performs, and interprets high resolution proteomics studies to improve target discovery, validation, and mechanism of action studies; offers specialized services to enhance discovery and validation of mechanistic biomarkers in peripheral fluids; and provides a set of bioinformatics tools to enhance data integration, and select regulated features and map to biological processes.
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.